Medibank Private Limited revised its financial guidance for the year ending June 30, 2016. For the period, the company expects premium revenue growth of between 4.5% and 5.0% previously the company forecasted above 5.5% and operating profit of above $470 million previously the company forecasted above $370 million. The revised targets anticipate that the second half operating profit will be lower than the first half due to increased marketing and brand investment, and some moderation of the recent slowdown in the growth of hospital utilisation rates.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.715 AUD | +0.68% | -1.46% | +4.35% |
27/06 | Medibank & Macquarie Group Reportedly May Acquire in HealthCare Space | CI |
05/06 | Australian Shares Rise as Q1 GDP Growth Misses Forecast; Horizon Minerals Jumps 14% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.35% | 685.38Cr | |
+12.00% | 985.39Cr | |
+5.99% | 556.55Cr | |
+73.44% | 374.79Cr | |
-2.03% | 237.78Cr | |
-6.03% | 123.54Cr | |
+84.03% | 76Cr | |
-6.27% | 14Cr | |
-19.75% | 5.95Cr |
- Stock Market
- Equities
- MPL Stock
- News Medibank Private Limited
- Medibank Private Limited Revises Financial Guidance for the Year Ending June 30, 2016